vTv Therapeutics Inc. Investing Cash Flow
vTv Therapeutics Inc. (VTVT) reported Investing Cash Flow of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-03-10
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $4.40M.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $0.00.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2022-12-31 was $0.00.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for the quarter ending 2022-09-30 was $0.00.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2023 was $4.40M.
- vTv Therapeutics Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$21.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | |||
| 2023-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.40M derived: sum of 2 quarters · filed 2026-03-10 | $4.40M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 derived: sum of 2 quarters · filed 2025-03-20 | -$21.00K 10-K · filed 2025-03-20 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$21.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$21.00K 10-Q · filed 2023-08-11 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $0.00 derived: sum of 2 quarters · filed 2024-03-13 | $0.00 10-K · filed 2024-03-13 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-06 | |||
| 2019-12-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $242.00K 10-K · filed 2022-03-29 | ||
| 2019-09-30 | $310.00K 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$5.00K derived: sum of 2 quarters · filed 2021-02-24 | -$5.00K derived: sum of 3 quarters · filed 2021-02-24 | $7.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$5.00K derived: sum of 2 quarters · filed 2019-10-30 | $7.00K 10-Q · filed 2019-10-30 | -$11.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $12.00K 10-Q · filed 2019-07-31 | -$6.00K derived: sum of 3 quarters · filed 2020-02-21 | $26.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $12.00K 10-Q · filed 2019-05-01 | -$6.00K derived: sum of 2 quarters · filed 2020-02-21 | $26.00K derived: sum of 3 quarters · filed 2020-02-21 | |
| 2017-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $14.00K derived: sum of 2 quarters · filed 2020-02-21 | -$25.00K 10-K · filed 2020-02-21 | |
| 2017-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$7.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$39.00K 10-Q · filed 2018-08-03 | |||
| 2016-12-31 | -$83.00K 10-K · filed 2019-02-26 |